English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/213389
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Exportar a otros formatos:

Title

Patient preference for oral chemotherapy in the treatment of metastatic breast and lung cancer

AuthorsCiruelos, Eva María; Díaz, María Nieves; Isla, María Dolores; López, Rafael; Bernabé Caro, Reyes; González, Encarnación; Cirauqui, Beatriz; Coves, Juan; Morales, Serafin; Arcediano, Alberto; Barneto, Isidoro; Cerezuela, Pablo; Illarramendi, José Juan; Morales, Cristina; Ponce, Santiago
KeywordsIntravenous administration
Metastasis
Oral administration
Patient preference
Quality of life
Tablets
Issue Date2019
PublisherJohn Wiley & Sons
Blackwell Publishing
CitationEuropean Journal of Cancer Care 28(6): e13164 (2019)
Abstract[Objectives]: Although new therapies against metastatic cancer have been developed in recent decades, chemotherapy is still an important treatment option. Prolonged treatment and side‐effects are often discouraging for patients, and in many cases, therapy is only palliative, not curative. This study explores patient preference for oral or intravenous (IV) chemotherapy in the treatment of metastatic breast or lung cancer. [Methods]: It is a descriptive, open label, multicentre, nation‐wide study, in which a 16‐item questionnaire consisting of single‐choice questions scored on a 5‐point Likert scale was administered to patients in a single visit, and another 11‐item questionnaire was self‐administered by the patient’s oncologist. [Results]: A total of 131 breast and lung cancer specialists at 64 hospitals enrolled 412 patients (lung cancer = 161; breast cancer = 251). To be eligible, patients must have already received IV therapy and at least 2 cycles of oral chemotherapy. Most (77%) patients expressed preference for oral therapy. Most considered their daily life was less disrupted with tablets (70.4%), had no trouble swallowing them (86.9%), and were not concerned about forgetting to take them (56.8%). Half (56.3%) were worried about problems related to drug infusion with IV therapy, 61.7% were concerned about nurses failing to find a suitable vein, and 63.1% were dissatisfied with hospital waiting times. A uniform response was obtained from both samples of patients. [Conclusion]: Convenience, ease of administration, fewer side effects and better quality of life tilt the balance towards oral drug administration.
Publisher version (URL)http://dx.doi.org/10.1111/ecc.13164
URIhttp://hdl.handle.net/10261/213389
DOIhttp://dx.doi.org/10.1111/ecc.13164
ISSN0961-5423
E-ISSN1365-2354
Appears in Collections:(IBIS) Artículos
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.